Stockscreener 앱 받기
42.99
0.32%
-0.14
전일 마감가:
$43.13
열려 있는:
$43.39
하루 거래량:
477.00K
Relative Volume:
0.38
시가총액:
$9.18B
수익:
$1.97B
순이익/손실:
$92.93M
주가수익비율:
105.73
EPS:
0.4066
순현금흐름:
$459.60M
1주 성능:
+1.22%
1개월 성능:
+12.36%
6개월 성능:
-4.90%
1년 성능:
-2.76%
1일 변동 폭
$42.94
$43.46
1주일 범위
$42.03
$43.46
52주 변동 폭
$37.74
$49.30
Qiagen Nv Stock (QGEN) Company Profile
QGEN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
QGEN
Qiagen Nv
|
42.99 | 9.18B | 1.97B | 92.93M | 459.60M | 0.4066 |
|
TMO
Thermo Fisher Scientific Inc
|
423.27 | 159.05B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
198.93 | 140.21B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
479.84 | 35.17B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
109.15 | 30.47B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
153.91 | 26.47B | 15.41B | 1.37B | 2.11B | 7.50 |
Qiagen Nv Stock (QGEN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-04 | 다운그레이드 | Redburn Atlantic | Buy → Neutral |
| 2025-02-19 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-01-06 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-12-10 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-10-17 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2024-06-27 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2023-12-19 | 개시 | Wells Fargo | Equal Weight |
| 2023-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2023-12-07 | 업그레이드 | Goldman | Neutral → Buy |
| 2023-09-12 | 개시 | Robert W. Baird | Outperform |
| 2023-05-23 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-10-18 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-01-18 | 업그레이드 | DZ Bank | Hold → Buy |
| 2021-10-15 | 재개 | Cowen | Market Perform |
| 2021-10-14 | 개시 | Redburn | Buy |
| 2021-07-14 | 다운그레이드 | Kepler | Buy → Hold |
| 2021-06-03 | 개시 | Goldman | Neutral |
| 2020-10-06 | 재개 | BofA Securities | Buy |
| 2020-09-28 | 업그레이드 | Kepler | Hold → Buy |
| 2020-08-24 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-08-20 | 재개 | JP Morgan | Overweight |
| 2020-08-17 | 업그레이드 | Berenberg | Hold → Buy |
| 2020-08-14 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2020-08-14 | 업그레이드 | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-04 | 다운그레이드 | Berenberg | Buy → Hold |
| 2020-01-08 | 개시 | Wells Fargo | Equal Weight |
| 2020-01-07 | 개시 | Citigroup | Neutral |
| 2019-12-26 | 재개 | BofA/Merrill | Underperform |
| 2019-11-15 | 개시 | Stifel | Hold |
| 2019-11-14 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2019-11-14 | 업그레이드 | JP Morgan | Underweight → Overweight |
| 2019-11-14 | 업그레이드 | Kepler | Reduce → Hold |
| 2019-10-17 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2019-10-09 | 다운그레이드 | Kepler | Hold → Reduce |
| 2019-10-08 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2019-10-08 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2019-10-08 | 다운그레이드 | JP Morgan | Neutral → Underweight |
모두보기
Qiagen Nv 주식(QGEN)의 최신 뉴스
Activist Fivespan has a stake in Qiagen. Here are 3 levers to boost the company's growth and improve value - NBC4 Washington
Global Molecular Diagnostics Market to Expand at a CAGR of ~9% by 2032 Due to the Rising Demand for Precision Medicine | DelveInsight - GlobeNewswire Inc.
Qiagen (QGEN) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
RNA Editing Market Deep Research 2025-2032 | QIAGEN N.V., ProQR - openPR.com
QIAGEN Expands Its Digital PCR Portfolio With New Lentivirus Solutions to Strengthen Cell and Gene Therapy Quality Control - DutchNews.nl
Why Qiagen (QGEN) is a Top Value Stock for the Long-Term - Yahoo Finance
QIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $300 Million - ADVFN
QIAGEN NV : UBS reiterates its Neutral rating - marketscreener.com
QIAGEN Advances Cancer Genomic Profiling With New Products and Partnership Updates at AACR Annual Meeting 2025 | QGEN Stock News - GuruFocus
QIAGEN Advances Cancer Genomic Profiling With New Products and Partnership Updates at AACR Annual Meeting 2025 - Yahoo Finance
Is There An Opportunity With Qiagen N.V.'s (NYSE:QGEN) 33% Undervaluation? - Yahoo Finance
QIAGEN N.V. Prepares to Release 2024 Financial Reports - TipRanks
PTA-AFR: QIAGEN N.V.: Pre-announcement of a financial report according to articles 114117 WpHG - TradingView
QIAGEN Advances Cancer Genomic Profiling With New Products and P - GuruFocus
Baird Increases Price Target for Qiagen (QGEN) Ahead of Q1 Resul - GuruFocus
What Qiagen N.V.'s (NYSE:QGEN) P/S Is Not Telling You - simplywall.st
Fivespan Said to Build Stake in Life Sciences Group Qiagen - MSN
Qiagen's Future Under The Microscope After Stake Purchase - Finimize
Qiagen’s Voting Rights Announcement Involves Major Financial Entities - TipRanks
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView
Why Qiagen (QGEN) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Fivespan Is Said to Build Stake in Life Sciences Group Qiagen - MSN
Activist investor Fivespan takes stake in QiagenBloomberg - MSN
Fivespan Partners Positions Itself in Qiagen (QGEN) Amid Activis - GuruFocus
Qiagen Holds Talks With Fivespan as Activist Investor Builds Stake - marketscreener.com
QIAGEN Advancing Plans to Launch Three New Sample Preparation Instruments by 2026 to Improve Lab Automation - 01net
QIAGEN's Lab Revolution: New Automation Systems Promise 3x Faster Sample Processing - Stock Titan
Qiagen (QGEN) Target Price Reduced Amid Negative Market Sentimen - GuruFocus
BofA Securities Cuts Price Target on Qiagen to $50 From $55, Maintains Buy Rating - MarketScreener
QIAGEN Announces Voting Rights Notification by AFM - TipRanks
Qiagen gains after guidance raise - MSN
Qiagen Announces Change in Total Voting Rights - TipRanks
PTA-NVR: QIAGEN N.V.: Total Voting Rights Announcement according to Article 41 of the WpHG - TradingView
QIAGEN N.V. to Release Results for Q1 2025 and Hold Webcast - sharewise.com
QIAGEN Earnings Alert: Key Q1 2025 Results Coming May 7What to Watch - Stock Titan
Qiagen Q1 Preliminary Adjusted Earnings Beat Guidance; 2025 Outlook Lifted -- Shares Rise - MarketScreener
Qiagen stock gains after guidance raise (QGEN:NYSE) - Seeking Alpha
Qiagen Nv (QGEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.15%
자본화:
|
볼륨(24시간):